Form 4: Select Medical Director Receives Restricted Stock Grant

Select Medical Holdings Corp. Director Daniel Thomas was granted 14,035 shares of restricted common stock, vesting on July 29, 2026.

Summary

• Daniel Thomas, a Director of Select Medical Holdings Corp. (SEM), was granted 14,035 shares of common stock.
• The transaction date for this grant was July 29, 2025.
• The shares were granted at a price of $0 per share, indicating a restricted stock award.
• Following this transaction, Daniel Thomas beneficially owns a total of 80,035 shares of common stock.
• The restricted stock is subject to certain exceptions and will vest in full on July 29, 2026, which is the first anniversary of the grant date.

Sentiment

Score: 7

Explanation: The filing indicates a routine compensation event for a director, which is generally positive as it aligns management interests with shareholder value. It does not present any negative or unexpected information.

Positives

• The grant of restricted stock to a director aligns their interests with those of shareholders, as the value of their compensation is tied to the company's future stock performance.
• Restricted stock grants are a common and accepted form of long-term incentive compensation for corporate directors.

Future Outlook

The restricted stock grant, with its future vesting date, indicates a commitment to long-term alignment between the director's interests and the company's performance.

Industry Context

The granting of restricted stock to directors is a standard practice across various industries for executive and board compensation, aiming to incentivize long-term value creation and retention.

Comparison to Industry Standards

• Restricted stock grants are a widely adopted compensation mechanism for directors in publicly traded companies, comparable to practices seen in healthcare and other sectors.
• The vesting schedule, typically over one to several years, is consistent with industry norms for aligning director incentives with sustained company performance.

Corporate Governance

Related Party Transactions

• The grant of restricted stock to Daniel Thomas, a Director, constitutes a transaction with a related party, which is a standard compensation practice.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with the company's long-term stock performance, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• The restricted stock granted to Daniel Thomas is expected to vest on July 29, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine restricted stock grant to a director, which is a common compensation practice aimed at aligning director interests with shareholder value. It does not contain information significant enough to alter a fundamental investment thesis, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Select Medical Holdings Corp, SEM, Restricted Stock, Stock Grant, Director Compensation, Insider Ownership, Form 4